Drug Recalls And Shortages - NAPLEX

1. What is the most common root cause category for injectable drug shortages?

   Manufacturing and quality problems (including remediation and capacity limits). Injectable shortages often stem from production issues like contamination or facility shutdowns, disrupting supply chains.

2. Which FDA resource is the standard reference for current U.S. drug shortages?

   FDA Drug Shortages database. This database tracks ongoing shortages with details on causes, durations, and alternatives to guide clinical decision-making.

3. Which pharmacy action best prevents further dispensing during a recall: destroy, quarantine, or reorder?

   Quarantine (segregate and label as recalled; do not dispense). Quarantining segregates recalled products, minimizing risk of accidental use while awaiting further recall directives.

4. What is a Class I drug recall (FDA definition) based on patient risk?

   Reasonable probability of serious adverse health consequences or death. Class I recalls involve the highest risk level where exposure could lead to severe health issues or fatality, requiring immediate action.

5. Which recall scope term means the product is recalled from the distribution chain only?

   Wholesale-level recall. Wholesale-level recalls stop distribution early in the supply chain, preventing further dissemination without reaching retail or consumers.

6. What is the first operational step a pharmacy should take after identifying a recalled lot?

   Quarantine and remove the affected lot from dispensing stock immediately. Immediate quarantine prevents dispensing, allowing time for manufacturer instructions on return or disposal to ensure safety.

7. What is the best immediate action if a patient presents a bottle from a recalled lot?

   Instruct the patient to stop using it and replace per recall guidance. Advising cessation and replacement follows recall protocols to protect patient health and comply with manufacturer or FDA guidance.

8. What is a typical recall reason when the labeled strength is higher or lower than actual?

   Potency/superpotent or subpotent product (assay out of specification). Potency deviations can lead to therapeutic failure or toxicity, violating quality standards and necessitating product removal.

9. What is a medical device safety action that is not a recall called by FDA?

   Safety alert (or safety notification). Safety alerts notify users of device risks without formal recall, focusing on usage precautions rather than product removal.

10. What is a Class III drug recall (FDA definition) based on patient risk?

    Not likely to cause adverse health consequences. Class III recalls are for violations unlikely to cause health issues, often involving labeling or minor defects without patient risk.

11. Which recall scope term means the product reached the consumer level?

    Consumer-level recall. Consumer-level recalls extend to end-users, requiring notifications and returns to mitigate risks at the patient level.

12. Which FDA resource is the primary database for recall announcements and details?

    FDA Enforcement Report. The Enforcement Report provides weekly updates on initiated recalls, including classifications and statuses for regulatory tracking.

13. What is the FDA definition of a drug shortage in practical terms for patient care?

    Supply does not meet current or projected demand at the patient level. Shortages occur when production or distribution fails to meet demand, impacting access to essential medications for patient care.

14. What is the difference between a market withdrawal and a recall?

    Market withdrawal is minor/voluntary; recall addresses a legal violation. Market withdrawals are voluntary for non-violative issues, while recalls enforce legal corrections for FDA-regulated violations.

15. What is an FDA drug recall, in one phrase, as used in pharmacy practice?

    Removal or correction of a marketed product that violates FDA laws. FDA recalls address violations of laws to protect public health by removing or correcting unsafe or misbranded products from the market.

16. What key identifiers should be matched to confirm a recalled product in inventory?

    NDC, lot/batch number, strength, dosage form, and expiration date. These identifiers ensure precise matching to affected products, preventing dispensing of recalled items and ensuring accurate inventory checks.

17. Which factor most determines whether patients must be contacted during a recall?

    Recall classification and consumer-level distribution with patient-level risk. High-risk classifications at consumer level necessitate outreach to inform patients and facilitate product returns or exchanges.

18. Which recall scope term means the product is recalled from pharmacies and wholesalers?

    Retail-level recall. Retail-level recalls target pharmacies and retailers to remove products before reaching consumers, limiting distribution scope.

19. Which recall class is highest urgency and requires the fastest action?

    Class I. Class I poses the greatest risk, necessitating urgent public notification and rapid product removal to prevent serious harm or death.

20. What is a Class II drug recall (FDA definition) based on patient risk?

    Temporary or medically reversible harm is possible; serious harm unlikely. Class II recalls apply when health consequences are temporary or reversible, with low probability of serious harm, but still warrant removal.

21. What recall reason describes particulate matter found in an injectable product?

    Foreign particulate contamination. Particulates in injectables can cause embolisms or reactions, violating purity standards and triggering safety-based recalls.

22. Which FDA web page is commonly used to search current and past recalls by product?

    FDA Recalls, Market Withdrawals, and Safety Alerts database. This database aggregates searchable recall information, enabling quick access to details for compliance and patient safety.

23. What recall reason describes the presence of the wrong drug or wrong strength in a package?

    Product mix-up or mislabeling (incorrect product/strength in container). Mix-ups risk incorrect dosing or therapy, compromising safety and efficacy, thus requiring recalls to correct distribution errors.

24. What is the most common quality defect category leading to sterile injectable recalls?

    Lack of sterility or microbial contamination risk. Sterility failures in injectables pose infection risks, prompting recalls to prevent microbial exposure in vulnerable patients.

25. Which single action best reduces patient harm when a shortage affects a critical medication?

    Therapeutic interchange to an evidence-based alternative with monitoring. Interchanging to alternatives maintains therapy continuity, with monitoring to ensure efficacy and minimize adverse effects during shortages.

Study these flashcards